Hokkaido, Japan

Rie Maezawa

This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Nipro Corporation, Sapporo Medical University. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rie Maezawa. Retrieved from https://idiyas.com/inventor/rie-maezawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.5

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rie Maezawa: Innovator in Brain Plasticity

Introduction

Rie Maezawa is a prominent inventor based in Hokkaido, Japan. She has made significant contributions to the field of neuroscience, particularly in the area of brain plasticity and synapse formation. Her innovative work aims to address critical health issues such as dementia and spinal cord injuries.

Latest Patents

Rie Maezawa holds a patent for a synapse formation agent. This invention relates to a synapse formation promoter and a brain plasticity promoter that comprises CD24-negative mesenchymal stem cells prepared from a patient's own bone marrow aspirate. The treatment targets conditions like dementia, chronic-phase cerebral infarction, chronic-phase spinal cord injury, and various mental diseases.

Career Highlights

Throughout her career, Rie has worked with esteemed institutions such as Sapporo Medical University and Nipro Corporation. Her research has been pivotal in advancing our understanding of brain health and recovery.

Collaborations

Rie has collaborated with notable colleagues, including Osamu Honmou and Masanori Sasaki. Their combined expertise has further enriched her research endeavors.

Conclusion

Rie Maezawa's innovative contributions to neuroscience highlight her dedication to improving brain health through her patented inventions. Her work continues to inspire advancements in medical treatments for neurological conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…